Srx is doing well. They do need the boost from the larger trials in a few years to really increase sales. Growth is good and it will be interesting to see the growth in marketing spend. Cost of goods also may be higher due to higher cost of isotopes. Exchange rate really hurting and it may stay this way for a while looking at the AUD. I hold an investment parcel in the bottom drawer but I'm more excited about BTA in the biotech area. Good result today for SIR spheres.
Ann: Fourth Quarter Doses Sales Growth of 23% , page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.40M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $61.98K | 351.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 11238850 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1266857 | 36 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |